TREA

97564810 - ORGANOX

Follow

Information

  • Trademark
  • 97564810
  • Serial Number
    97564810
  • Filing Date
    August 25, 2022
    2 years ago
  • Transaction Date
    July 16, 2024
    2 months ago
  • Status Date
    July 16, 2024
    2 months ago
  • Published for Opposition Date
    December 05, 2023
    9 months ago
  • Location Date
    January 30, 2024
    7 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    GOLDEN, LAURA DAWN
  • Attorney Docket Number
    A325-86
    Attorney Name
    Ben Natter
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ORGANOX
Case File Statements
  • GS0051: Medical and veterinary preparations, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for use with organs ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for transplant organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion solutions for organs in vivo and ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; therapeutic preparations for organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; medical and veterinary preparations for the perfusion of organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; nutrition for organs ex vivo, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs, namely, perfusion fluids containing minerals, salts, vitamins, amino acids, proteins, enzymes and other beneficial formulations for organs in vivo and ex vivo; pharmaceuticals for treating organs in vivo or ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in for maintaining and improving the quality of organs in vivo or ex vivo; biological preparations for the maintenance of organs inside or outside human or animal bodies, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the preservation, treatment, and transplant of organs
  • GS0101: Medical and veterinary apparatus and instruments, namely, system for use in artificial organ support; medical and veterinary apparatus and instruments for preserving organs and body parts, namely, systems for use in artificial organ support and in preserving the viability of organs for use in transplantation; medical and veterinary apparatus for perfusing organs inside or outside human or animal bodies, namely, system for use in artificial organ support; electromagnetic medical diagnostic imaging apparatus, namely, medical and veterinary apparatus for enabling functional assessment of donor transplant organs during storage and transportation; normothermic apparatus for ex vivo organs, namely, warming device for stabilizing organ temperature for medical purposes; component parts for all the aforesaid goods
  • GS0421: Scientific research and development in the fields of maintenance, preservation, transportation and storage of organs in vivo and ex vivo; scientific research and development in relation to the perfusion of donor transplant organs; medical research services in relation to maintaining and improving the quality of organs in vivo or ex vivo; medical and pharmacological research services; product quality and safety testing, namely, conducting efficacy and toxicity testing of pharmaceuticals for others; pharmaceutical research services, namely, conducting pharmacological testing on organs and body parts in vivo or ex vivo, being testing of pharmaceuticals; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the aforesaid services
Case File Event Statements
  • 6/28/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/29/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/14/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/12/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/28/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/28/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/18/2023 - 12 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/18/2023 - 12 months ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/18/2023 - 12 months ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/21/2023 - 12 months ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/21/2023 - 12 months ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/21/2023 - 12 months ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/20/2023 - 11 months ago
    13 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 10/20/2023 - 11 months ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/20/2023 - 11 months ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/27/2023 - 10 months ago
    16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/27/2023 - 10 months ago
    17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/27/2023 - 10 months ago
    18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/27/2023 - 10 months ago
    19 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/27/2023 - 10 months ago
    20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/5/2023 - 9 months ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/5/2023 - 9 months ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/30/2024 - 7 months ago
    24 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/16/2024 - 2 months ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/16/2024 - 2 months ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/16/2024 - 2 months ago
    26 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/16/2024 - 2 months ago
    27 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 11/15/2023 - 10 months ago
    21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP